UCB's CIMZIA® (certolizumab pegol) approved by the US FDA for ... - Euronext (persbericht)
UCB's CIMZIA® (certolizumab pegol) approved by the US FDA for ... - Euronext (persbericht) - UCB's CIMZIA® (certolizumab pegol) approved by the US FDA for ...Euronext (persbericht), NetherlandsIn the pivotal clinical trials, reported serious adverse reactions were infections including tuberculosis and malignancies including lymphoma. The most commonly occurring adverse events were upper respiratory tract infections, rash and urinary tract ... [Google TB NEWS]
- Editor's blog
- Login or register to post comments


